MedTrace Logo

Patient and Care Partner Experiences Living With Multiple Myeloma (PaCE-MM)

NCT05276622 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 64

Last updated 2024-12-12

No results posted yet for this study

Summary

This research study is explore the impact over time of multiple myeloma and its associated treatments on the physical and cognitive function and quality of life of patients and their care partners and how these impacts affect the overall illness experience.

Conditions

Interventions

OTHER

Comprehensive Geriatric Assessment

A modified Cancer and Aging Research Group (CARG) Geriatric Assessment that includes validated measures of 7 geriatric domains: functional status, comorbidity, cognition, psychological state, social activity, and support, nutritional status, and medications will be performed at baseline (pre-treatment), every 3 months for a total of 3 assessments. The modified comprehensive Geriatric Assessment includes patient-reported surveys and research staff assessments. Cognitive Testing: The National Institutes of Health Toolbox Cognition Battery (objective) and PROMIS Short Form v2.0 - Cognitive function 8a (subjective)

OTHER

Qualitative patient-care partner interviews

Semi-structured Interviews: Baseline and again at 3 months.

OTHER

Surveys on well-being and function

Care partner's Surveys on well-being and function: Baseline and again at 3 months

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • UNC Lineberger Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Shakira Grant, MBBS · Lineberger CCC, Center for Aging and Health, The University of North Carolina Chapel Hill

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-08
Primary Completion
2023-10-03
Completion
2023-10-03

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05276622 on ClinicalTrials.gov